Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.160 | 5 | 111069977 | upstream gene variant | A/G | snv | 0.51 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.720 | 1.000 | 3 | 2011 | 2016 | |||||||
|
0.925 | 0.160 | 5 | 111069977 | upstream gene variant | A/G | snv | 0.51 |
|
Digestive System Diseases; Immune System Diseases; Hemic and Lymphatic Diseases | 0.720 | 1.000 | 2 | 2010 | 2015 | |||||||
|
0.851 | 0.160 | 5 | 111072304 | intron variant | C/T | snv | 0.25 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.710 | 1.000 | 2 | 2011 | 2019 | |||||||
|
1.000 | 0.080 | 5 | 111069301 | upstream gene variant | A/C | snv | 0.24 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 5 | 111069301 | upstream gene variant | A/C | snv | 0.24 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.080 | 5 | 111069301 | upstream gene variant | A/C | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.160 | 5 | 111072304 | intron variant | C/T | snv | 0.25 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.851 | 0.160 | 5 | 111072304 | intron variant | C/T | snv | 0.25 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.080 | 5 | 111073369 | 5 prime UTR variant | C/A;G;T | snv |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.925 | 0.160 | 5 | 111069977 | upstream gene variant | A/G | snv | 0.51 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.360 | 5 | 111071044 | 5 prime UTR variant | C/A;T | snv | 0.40 |
|
Digestive System Diseases; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.807 | 0.360 | 5 | 111071044 | 5 prime UTR variant | C/A;T | snv | 0.40 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.882 | 0.160 | 5 | 111071809 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.030 | 1.000 | 3 | 2010 | 2014 | |||||||
|
0.807 | 0.360 | 5 | 111071044 | 5 prime UTR variant | C/A;T | snv | 0.40 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2011 | 2014 | |||||||
|
1.000 | 0.120 | 5 | 111072481 | intron variant | C/A | snv | 0.13 |
|
Digestive System Diseases; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.925 | 0.120 | 5 | 111076887 | 3 prime UTR variant | A/G | snv | 0.15 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 5 | 111076887 | 3 prime UTR variant | A/G | snv | 0.15 |
|
Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.160 | 5 | 111072304 | intron variant | C/T | snv | 0.25 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.160 | 5 | 111072304 | intron variant | C/T | snv | 0.25 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.160 | 5 | 111071809 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.160 | 5 | 111071809 | 5 prime UTR variant | C/T | snv | 0.27 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.080 | 5 | 111073369 | 5 prime UTR variant | C/A;G;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.080 | 5 | 111073369 | 5 prime UTR variant | C/A;G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.827 | 0.200 | 5 | 111073450 | 5 prime UTR variant | C/G | snv | 8.7E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.200 | 5 | 111073450 | 5 prime UTR variant | C/G | snv | 8.7E-02 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |